Sophie Viaud

Affiliations: 
California Institute for Biomedical Research 
Google:
"Sophie Viaud"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pennell CA, Campbell H, Storlie MD, et al. (2022) Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19 malignancy. Journal For Immunotherapy of Cancer. 10
Viaud S, Ma JSY, Hardy IR, et al. (2018) Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory. Proceedings of the National Academy of Sciences of the United States of America
Huang H, Viaud S, Theofilopoulos AN, et al. (2018) AI-04 Immunotherapy for lupus in a mouse model to define pathogenesis and therapeutic targeting Lupus Science & Medicine. 5
Besse B, Charrier M, Lapierre V, et al. (2016) Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology. 5: e1071008
Pitt JM, Charrier M, Viaud S, et al. (2014) Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. Journal of Immunology (Baltimore, Md. : 1950). 193: 1006-11
Viaud S, Daillère R, Boneca IG, et al. (2014) Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death and Differentiation. 22: 199-214
Viaud S, Daillère R, Yamazaki T, et al. (2014) Why should we need the gut microbiota to respond to cancer therapies? Oncoimmunology. 3: e27574
Viaud S, Saccheri F, Mignot G, et al. (2013) The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (New York, N.Y.). 342: 971-6
Hannani D, Locher C, Yamazaki T, et al. (2013) Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines. Cell Death and Differentiation. 21: 50-8
Viaud S, Ploix S, Lapierre V, et al. (2011) Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ. Journal of Immunotherapy (Hagerstown, Md. : 1997). 34: 65-75
See more...